Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTER
NCT04291508Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetaminophen, ascorbic acid in sepsis, sponsored by Massachusetts General Hospital. Started Oct 2021; status: completed.
02
Drugs
acetaminophenascorbic acid
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04291508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04291508.